Brief: Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products
08/09/2017 17:06
Sept 8 (Reuters) - Vanc Pharmaceuticals Inc VANC.V
* Vanc pharmaceuticals receives health canada class-iii
approval for ferrous fumarate products
* Vanc pharmaceuticals inc - has received health canada
class-iii approval of ferrous fumarate tablets and capsules for
use in iron deficiency anemia
* Vanc pharmaceuticals inc - that it will not be proceeding
with 2nd tranche closing of non-brokered private placement
announced july 20, 2017
* Vanc pharmaceuticals inc - plans to secure additional
financing in due course
Source text for Eikon: ID:nGNXOECZCa
Further company coverage: VANC.V
((Bangalore.newsroom@thomsonreuters.com;))